Halozyme Therapeutics Inc (NASDAQ:HALO)

17.35
Delayed Data
As of May 29
 -0.33 / -1.87%
Today’s Change
7.51
Today|||52-Week Range
18.18
+79.79%
Year-to-Date

Today’s Trading

Previous close17.68
Today’s open17.74
Day’s range17.28 - 17.88
Volume1,137,977
Average volume (3 months)1,370,565
Market cap$2.2B
Dividend yield--
Data as of 3:59pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+15.68%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book52.75

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+2.59+4.93%
NVAXNovavax Inc+0.16+1.81%
ESPREsperion Therapeutic...+2.16+2.05%
RDUSRadius Health Inc+0.28+0.58%
Data as of 4:14pm ET, 05/29/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers